These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36640930)

  • 21. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection.
    de la Calle C; Lalueza A; Mancheño-Losa M; Maestro-de la Calle G; Lora-Tamayo J; Arrieta E; García-Reyne A; Losada I; de Miguel B; Díaz-Simón R; López-Medrano F; Fernández-Ruiz M; Carretero O; San Juan R; Aguado JM; Lumbreras C
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1209-1216. PubMed ID: 33409832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.
    Wongvibulsin S; Garibaldi BT; Antar AAR; Wen J; Wang MC; Gupta A; Bollinger R; Xu Y; Wang K; Betz JF; Muschelli J; Bandeen-Roche K; Zeger SL; Robinson ML
    Ann Intern Med; 2021 Jun; 174(6):777-785. PubMed ID: 33646849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of correlation between the SARS-CoV-2 cycle threshold (C
    Camargo JF; Lin RY; Komanduri KV
    J Med Virol; 2021 Oct; 93(10):6059-6062. PubMed ID: 34196409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal viral load at admission is not an independent predictor of thromboembolic complications in unvaccinated COVID-19 hospitalized patients.
    Ontiveros N; Del Bosque-Aguirre A; Gonzalez-Urquijo M; Hinojosa Gonzalez DE; Martinez-Resendez MF; Schang L; Fabiani MA
    J Thromb Thrombolysis; 2023 Feb; 55(2):282-288. PubMed ID: 36564590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
    Han M; Xu M; Zhang Y; Liu Z; Li S; He T; Li J; Gao Y; Liu W; Li T; Chen Z; Huang X; Cheng G; Wang J; Dittmer U; Witzke O; Zou G; Li X; Lu M; Zhang Z
    Med Microbiol Immunol; 2020 Dec; 209(6):657-668. PubMed ID: 32860073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial.
    Pantazopoulos I; Chalkias A; Mavrovounis G; Dimeas I; Sinis S; Miziou A; Rouka E; Poulas K; Gourgoulianis K
    Can Respir J; 2022; 2022():8794127. PubMed ID: 36247079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.
    Arora R; Goel R; Kumar S; Chhabra M; Saxena S; Manchanda V; Pumma P
    Ophthalmology; 2021 Apr; 128(4):494-503. PubMed ID: 32882309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.
    Buchan BW; Hoff JS; Gmehlin CG; Perez A; Faron ML; Munoz-Price LS; Ledeboer NA
    Am J Clin Pathol; 2020 Sep; 154(4):479-485. PubMed ID: 32687186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Viral Load Cycle Threshold Values in Patients with SARS-CoV-2 Associated Pneumonia with Real-Time PCR Method.
    Bakir A; Hosbul T; Cuce F; Artuk C; Taskin G; Caglayan M; Guney M; Kurkcu MF; Yildiz F; Erdal H; Erdem G
    J Infect Dev Ctries; 2021 Oct; 15(10):1408-1414. PubMed ID: 34780363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of admission viral load on respiratory outcomes in hospitalized SARS-CoV-2 infected patients with cancer and without cancer: A 2-, 4- and 6-months follow-up prospective study.
    Al-Mozaini M; Karim AR; Islam SS
    J Infect Public Health; 2023 Aug; 16(8):1209-1219. PubMed ID: 37276715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
    Wu P; Duan F; Luo C; Liu Q; Qu X; Liang L; Wu K
    JAMA Ophthalmol; 2020 May; 138(5):575-578. PubMed ID: 32232433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
    Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 persistence in immunocompromised children.
    Dolan SA; Mulcahy Levy J; Moss A; Pearce K; Butler M; Jung S; Dominguez SR; Mwangi E; Maloney K; Rao S
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29277. PubMed ID: 34453477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients?
    Aydin S; Benk IG; Geckil AA
    J Virol Methods; 2021 Aug; 294():114198. PubMed ID: 34044003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.